Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
MedTech
Novo Nordisk pens GLP-1 implant tech deal with Vivani Medical
As Novo Nordisk continues to look for new ways to broaden its semaglutide GLP-1 franchise, it has signed a new deal with Vivani Medical to help.
Ben Adams
Jul 7, 2026 9:07am
Fierce Pharma
Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce
Jun 11, 2026 7:00am
BrightGene's oral drug sees up to 8% weight loss in early data
Mar 25, 2026 4:04am
Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test
Mar 19, 2026 6:45am
Skye links CB1-Wegovy combo to 22.3% weight loss after a year
Feb 2, 2026 8:08am
Lilly rounds out orforglipron data ahead of obesity filings
Sep 17, 2025 9:00am
